Luye Pharma Competitors and Similar CompaniesClear all

Luye Pharma's competitors and similar companies include Livzon Pharmaceutical Group, Hisamitsu Pharmaceutical, Dragonfly and Oscotec.
Luye Pharma
Luye Pharma
Luye Pharma Group (绿叶制药) is a pharmaceutical company that develops, manufactures, and sells medications.
Livzon Pharmaceutical Group
Livzon Pharmaceutical Group
Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.
Hisamitsu Pharmaceutical
Hisamitsu Pharmaceutical
Hisamitsu Pharmaceutical (久光製藥株式會社) is a company manufacturing external analgesic and anti-inflammatory preparations, such as medicated plasters, gels, sprays, etc.
Dragonfly
Dragonfly
Dragonfly Therapeutics is a company developing drugs targeted at natural killer cells and other cells of the body's innate immune system to eliminate cancer.
Oscotec
Oscotec
Oscotec is a clinical stage drug discovery and development company.
Founding Date
Founding Date
1994
Founding Date
1985
Founding Date
1847
Founding Date
2015
Founding Date
1998
Type
Type
Public
Type
Public
Type
Public
Type
Private
Type
Public
Tags
Locations
Locations
CN HQ
Locations
Zhuhai, CN HQ
Chengdu, CN
Qingyuan, CN
Shanghai, CN
Shaoguan, CN
Shenzhen, CN
Zhuhai, CN
Locations
Tosu, JP HQ
Manaus, BR
Beijing, CN
Suzhou, CN
Hong Kong, HK
Sidoarjo, ID
Fukuoka, JP
see more
Locations
Waltham, US HQ
Locations
Seongnam-si, KR HQ
Employees
Employees
5,150
Employees
9,067
Employees
2,759
Employees
109
Employees
50

Financial

Revenue (est.)
Revenue (est.)
¥6.3b (FY, 2025)
Revenue (est.)
¥11.7b (FY, 2025)
Revenue (est.)
¥163b (FY, 2026)
Revenue (est.)
N/A
Revenue (est.)
₩99.8b (FY, 2025)
Cost of goods
Cost of goods
¥1.3b (FY, 2025)
Cost of goods
¥4.1b (FY, 2025)
Cost of goods
¥59.9b (FY, 2026)
Cost of goods
N/A
Cost of goods
₩438.8m (FY, 2025)
Gross profit
Gross profit
¥5.1b (FY, 2025)
Gross profit
¥7.8b (FY, 2025)
Gross profit
¥103.2b (FY, 2026)
Gross profit
N/A
Gross profit
₩100b (FY, 2025)
Net income
Net income
¥705.7m (FY, 2025)
Net income
¥2.4b (FY, 2025)
Net income
¥19.6b (FY, 2026)
Net income
N/A
Net income
₩54.4b (FY, 2025)
For sources of this data, please see the company profile

View Company Profiles

Livzon Pharmaceutical Group
HQ
Zhuhai, CN
Employees
9,067

Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.

View company
Hisamitsu Pharmaceutical
HQ
Tosu, JP
Employees
2,759

Hisamitsu Pharmaceutical (久光製藥株式會社) is a company manufacturing external analgesic and anti-inflammatory preparations, such as medicated plasters, gels, sprays, etc.

View company
Dragonfly
HQ
Waltham, US
Employees
109

Dragonfly Therapeutics is a company developing drugs targeted at natural killer cells and other cells of the body's innate immune system to eliminate cancer.

View company
Oscotec
HQ
Seongnam-si, KR
Employees
50

Oscotec is a clinical stage drug discovery and development company.

View company